MedTrace Logo

Treatment of Peritoneal Carcinomatosis With Pressurized IntraPeritoneal Aerosol Chemotherapy -

NCT03287375 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 143

Last updated 2022-10-07

No results posted yet for this study

Summary

This is a study, where the efficacy of Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) against peritoneal metastases will be evaluated. Furthermore, this study will focus on the best evaluation method, where both Quality of Life questionnaires, repeated histology, cytology and MRI will be used.

Conditions

  • Peritoneum; Carcinomatosis
  • Peritoneal Neoplasms
  • Peritoneal Metastases
  • Chemotherapy Effect
  • Chemotherapeutic Toxicity
  • Quality of Life
  • Histologic Progression

Interventions

DRUG

PIPAC

Sponsors & Collaborators

  • Michael Bau Mortensen

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-01
Primary Completion
2022-02-01
Completion
2022-10-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03287375 on ClinicalTrials.gov